BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19733372)

  • 21. Women's anxieties caused by false positives in mammography screening: a contingent valuation survey.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Breast Cancer Res Treat; 2007 Jan; 101(1):59-64. PubMed ID: 16821083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer screening for women 40 to 49 years of age: what is a clinician to do?
    Gemignani ML
    Obstet Gynecol; 2007 Sep; 110(3):548-9. PubMed ID: 17766597
    [No Abstract]   [Full Text] [Related]  

  • 23. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of breast cancer: results of a screening programme.
    Beahrs OH
    Ann R Coll Surg Engl; 1980 Jan; 62(1):38-40. PubMed ID: 7362187
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with breast cancer, pre-screening perceived susceptibility and the psychological impact of screening.
    Absetz P; Aro AR; Sutton SR
    Psychooncology; 2003 Jun; 12(4):305-18. PubMed ID: 12748969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.
    Singh D; Pitkäniemi J; Malila N; Anttila A
    Breast Cancer Res Treat; 2016 Sep; 159(2):305-13. PubMed ID: 27496148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
    Roman M; Skaane P; Hofvind S
    Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram.
    Henderson LM; Hubbard RA; Sprague BL; Zhu W; Kerlikowske K
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1882-9. PubMed ID: 26631292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk is increased in the years following false-positive breast cancer screening.
    Goossens MC; De Brabander I; De Greve J; Vaes E; Van Ongeval C; Van Herck K; Kellen E
    Eur J Cancer Prev; 2017 Sep; 26(5):396-403. PubMed ID: 27749382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients.
    Obi N; Waldmann A; Schäfer F; Schreer I; Katalinic A
    Cancer Epidemiol; 2011 Jun; 35(3):286-92. PubMed ID: 20920901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The eternal problem of false positives in mammography screening].
    Seguí Díaz M
    Semergen; 2017 Mar; 43(2):151-153. PubMed ID: 27117788
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefit and harm associated with screening for breast cancer.
    Sox HC
    N Engl J Med; 1998 Apr; 338(16):1145-6. PubMed ID: 9545364
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast cancer screening--when do we start and how often should it be done?
    Fenton A; Panay N
    Climacteric; 2011 Oct; 14(5):513-4. PubMed ID: 21910669
    [No Abstract]   [Full Text] [Related]  

  • 35. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
    Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
    Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic invasiveness and psychosocial consequences of false-positive mammography.
    Heleno B; Siersma VD; Brodersen J
    Ann Fam Med; 2015; 13(3):242-9. PubMed ID: 25964402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The background review for the USPSTF recommendation on screening for breast cancer.
    DeFrank JT; Brewer NT
    Ann Intern Med; 2010 Apr; 152(8):537-8; author reply 538-9. PubMed ID: 20157111
    [No Abstract]   [Full Text] [Related]  

  • 39. Balancing mammography's benefits and harms.
    Fenton JJ; Elmore JG
    BMJ; 2004 Jun; 328(7453):E301-2. PubMed ID: 15191996
    [No Abstract]   [Full Text] [Related]  

  • 40. [Validation of a questionnaire to assess consumer satisfaction with mammography screening, Rome (Italy)].
    Semyonov L; Boggi R; Napoli M; Ravelli G; Fulgenzi R; Landi A; La Torre G
    Ig Sanita Pubbl; 2015; 71(4):433-46. PubMed ID: 26519749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.